FDA takes first step in possible reversal of ban on some peptides The Washington Post RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and